NUVB Nuvation Bio Inc.
NYSE · SEC CIK 1811063 · EDGAR
- Bought, last 12 months
- $118.3K 1 purchases by 1 insiders
- Sold, last 12 months
- $9.68M 14 sales by 6 insiders
- Filings on record
- 131 since 2021-11-01, latest 2026-08-21 16:49
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Hattersley Gary | CSO | — | $3.88M |
| Liu Dongfang | Chief MEDICAL Off | — | $1.87M |
| Wentworth Kerry | Chief REGULATORY Off | — | $1.47M |
| Hanley David C. | CHIEF TECHNICAL Ops | — | $1.43M |
| Markel Stacy | CHRO | — | $753.2K |
| Sauvage Philippe | CFO | — | $286.4K |
| Mashal Robert | Dir | $118.3K | — |
| Makunje Moses | SEE REMARKS | — | — |
Transactions 64
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-21 16:49 | 2026-08-19 | NUVB | Hattersley Gary | CSO | M - OptEx | $1.87 | +100.0K | 100.0K | New | +$187.0K |
| DT | 2026-08-21 16:49 | 2026-08-19 | NUVB | Hattersley Gary | CSO | S - Sale+OE | $7.09 | -100.0K | 0 | -100% | -$709.2K |
| DM | 2026-07-17 18:27 | 2026-07-15 | NUVB | Sauvage Philippe | CFO | M - OptEx | $2.17 | +40.0K | 54.1K | +283% | +$86.8K |
| DMT | 2026-06-24 19:09 | 2026-06-23 | NUVB | Markel Stacy | CHRO | M - OptEx | $1.83 | +125.0K | 157.6K | +384% | +$229.2K |
| DT | 2026-06-24 19:09 | 2026-06-23 | NUVB | Markel Stacy | CHRO | S - Sale+OE | $6.03 | -125.0K | 32.6K | -79% | -$753.2K |
| DT | 2026-06-24 19:07 | 2026-06-23 | NUVB | Wentworth Kerry | Chief REGULATORY Off | M - OptEx | $2.93 | +63.0K | 116.0K | +119% | +$184.6K |
| DT | 2026-06-24 19:07 | 2026-06-23 | NUVB | Wentworth Kerry | Chief REGULATORY Off | S - Sale+OE | $6.02 | -63.0K | 53.0K | -54% | -$379.2K |
| DT | 2026-06-24 19:07 | 2026-06-23 | NUVB | Sauvage Philippe | CFO | M - OptEx | $2.17 | +47.7K | 60.3K | +376% | +$103.4K |
| DT | 2026-06-24 19:07 | 2026-06-23 | NUVB | Sauvage Philippe | CFO | S - Sale+OE | $6.01 | -47.7K | 12.7K | -79% | -$286.4K |
| I | 2026-06-11 20:02 | 2026-06-09 | NUVB | Mashal Robert | Dir | P - Purchase | $4.73 | +25.0K | 225.0K | +12% | +$118.3K |
| DT | 2026-04-21 16:35 | 2026-04-17 | NUVB | Wentworth Kerry | Chief REGULATORY Off | M - OptEx | $2.93 | +36.8K | 89.8K | +69% | +$107.7K |
| DT | 2026-04-21 16:35 | 2026-04-17 | NUVB | Wentworth Kerry | Chief REGULATORY Off | S - Sale+OE | $5.01 | -36.8K | 53.0K | -41% | -$184.3K |
| DT | 2026-04-21 16:34 | 2026-04-17 | NUVB | Liu Dongfang | Chief MEDICAL Off | M - OptEx | $1.94 | +50.0K | 68.0K | +278% | +$97.0K |
| DT | 2026-04-21 16:34 | 2026-04-17 | NUVB | Liu Dongfang | Chief MEDICAL Off | S - Sale+OE | $5.02 | -50.0K | 18.0K | -74% | -$251.0K |
| DMT | 2026-04-08 16:23 | 2026-04-06 | NUVB | Wentworth Kerry | Chief REGULATORY Off | M - OptEx | $1.91 | +200.0K | 253.0K | +377% | +$381.0K |
| DT | 2026-04-08 16:23 | 2026-04-06 | NUVB | Wentworth Kerry | Chief REGULATORY Off | S - Sale+OE | $4.52 | -200.0K | 53.0K | -79% | -$903.6K |
| D | 2026-03-03 | 2026-02-27 | NUVB | Makunje Moses | SEE REMARKS | A - Grant | $0.00 | +50.8K | 68.1K | +292% | $0 |
| D | 2025-12-03 | 2025-12-01 | NUVB | Liu Dongfang | Chief MEDICAL Off | M - OptEx | $2.93 | +150.0K | 168.0K | +833% | +$439.5K |
| D | 2025-12-03 | 2025-12-01 | NUVB | Liu Dongfang | Chief MEDICAL Off | S - Sale+OE | $7.82 | -150.0K | 18.0K | -89% | -$1.17M |
| DM | 2025-11-26 | 2025-11-25+ | NUVB | Liu Dongfang | Chief MEDICAL Off | S - Sale+OE | $7.75 | -20.0K | 18.0K | -53% | -$155.0K |
| DM | 2025-11-26 | 2025-11-25+ | NUVB | Liu Dongfang | Chief MEDICAL Off | M - OptEx | $3.61 | +20.0K | 28.0K | +250% | +$72.2K |
| DM | 2025-11-24 | 2025-11-20 | NUVB | Hattersley Gary | CSO | M - OptEx | $1.90 | +369.1K | 300.0K | New | +$702.1K |
| DM | 2025-11-24 | 2025-11-20 | NUVB | Hattersley Gary | CSO | S - Sale+OE | $7.23 | -369.1K | 0 | -100% | -$2.67M |
| D | 2025-11-24 | 2025-11-20 | NUVB | Liu Dongfang | Chief MEDICAL Off | M - OptEx | $1.87 | +20.0K | 38.0K | +111% | +$37.4K |
| D | 2025-11-24 | 2025-11-20 | NUVB | Liu Dongfang | Chief MEDICAL Off | S - Sale+OE | $7.00 | -20.0K | 18.0K | -53% | -$140.0K |
| D | 2025-11-21 | 2025-11-19 | NUVB | Hanley David C. | CHIEF TECHNICAL Ops | M - OptEx | $1.87 | +200.0K | 224.0K | +833% | +$374.0K |
| D | 2025-11-21 | 2025-11-19 | NUVB | Hanley David C. | CHIEF TECHNICAL Ops | S - Sale+OE | $7.14 | -200.0K | 24.0K | -89% | -$1.43M |
| DM | 2025-11-19 | 2025-11-17+ | NUVB | Liu Dongfang | Chief MEDICAL Off | M - OptEx | $1.87 | +30.0K | 30.0K | New | +$56.1K |
| DM | 2025-11-19 | 2025-11-17+ | NUVB | Liu Dongfang | Chief MEDICAL Off | S - Sale+OE | $4.93 | -30.0K | 15.0K | -67% | -$148.1K |
| D | 2025-10-29 | 2025-10-27 | NUVB | Hattersley Gary | CSO | S - Sale+OE | $5.02 | -100.0K | 0 | -100% | -$502.0K |
| D | 2025-10-29 | 2025-10-27 | NUVB | Hattersley Gary | CSO | M - OptEx | $1.74 | +100.0K | 100.0K | New | +$174.0K |
| M | 2025-06-18 | 2025-06-16 | NUVB | Wentworth Kerry | Chief REGULATORY Off | P - Purchase | $1.79 | +50.0K | 26.0K | New | +$89.7K |
| 2025-06-18 | 2025-06-18 | NUVB | Markel Stacy | CHRO | P - Purchase | $1.71 | +10.0K | 29.6K | +51% | +$17.1K | |
| 2025-06-18 | 2025-06-16 | NUVB | Sjogren Colleen | Chief Commercial Off | P - Purchase | $1.81 | +50.0K | 81.0K | +161% | +$90.5K | |
| 2025-06-18 | 2025-06-16 | NUVB | Hung David | Pres AND CEO, Dir, 10% | P - Purchase | $1.79 | +500.0K | 59.28M | +0.9% | +$895.0K | |
| M | 2025-06-18 | 2025-06-16+ | NUVB | Sauvage Philippe | CFO | P - Purchase | $1.81 | +7,300 | 9,902 | +281% | +$13.2K |
| D | 2025-05-06 | 2025-05-02 | NUVB | Liu Dongfang | Chief MEDICAL Off | S - Sale+OE | $2.50 | -20.0K | 12.0K | -62% | -$50.0K |
| D | 2025-05-06 | 2025-05-02 | NUVB | Liu Dongfang | Chief MEDICAL Off | M - OptEx | $1.94 | +20.0K | 32.0K | +167% | +$38.8K |
| M | 2025-04-08 | 2025-04-04+ | NUVB | Hung David | Pres AND CEO, Dir, 10% | P - Purchase | $1.64 | +500.0K | 58.78M | +0.9% | +$821.0K |
| MI | 2025-04-03 | 2025-04-01 | NUVB | Mashal Robert | Dir | P - Purchase | $1.67 | +100.0K | 101.1K | +9,091% | +$167.0K |
| 2024-11-13 | 2024-11-11 | NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD, Dir | S - Sale | $2.89 | -56.4K | 3.87M | -1% | -$162.9K | |
| MI | 2024-10-10 | 2024-10-08 | NUVB | Mashal Robert | Dir | P - Purchase | $2.20 | +100.0K | 100.0K | New | +$220.0K |
| DI | 2024-09-05 | 2024-09-04 | NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD, Dir | C - Cnv Deriv | — | +1.70M | 2.25M | +308% | — |
| D | 2024-09-05 | 2024-09-04 | NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD, Dir | C - Cnv Deriv | — | +2.54M | 3.92M | +184% | — |
| DMI | 2024-09-05 | 2024-09-04 | NUVB | Cui Xiangmin | Dir | C - Cnv Deriv | — | +19.00M | 7.61M | New | — |
| I | 2024-06-26 | 2024-06-25 | NUVB | Cui Xiangmin | Dir | P - Purchase | $2.97 | +277.9K | 2.45M | +13% | +$825.3K |
| MI | 2024-06-25 | 2024-06-20+ | NUVB | Cui Xiangmin | Dir | P - Purchase | $2.98 | +500.0K | 1.76M | +40% | +$1.49M |
| I | 2024-06-13 | 2024-06-11 | NUVB | BLICKENSTAFF KIM D | Dir | P - Purchase | $2.90 | +172.2K | 172.2K | New | +$499.3K |
| DM | 2024-05-29 | 2024-05-24 | NUVB | WELCH DANIEL G | Dir | M - OptEx | $1.68 | +659.9K | 659.9K | New | +$1.11M |
| D | 2024-04-11 | 2024-04-09 | NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD, Dir | A - Grant | $0.00 | +1.38M | 1.38M | New | $0 |
| DI | 2024-04-11 | 2024-04-09 | NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD, Dir | A - Grant | $0.00 | +550.8K | 550.8K | New | $0 |
| MI | 2024-04-11 | 2024-04-09 | NUVB | Cui Xiangmin | Dir | A - Grant | — | +6.17M | 4.18M | New | — |
| MAI | 2023-09-22 | 2023-09-19+ | NUVB | EcoR1 Capital Fund Qualified, L.P. | Dir | P - Purchase | $1.26 | +5.31M | 12.50M | +74% | +$6.71M |
| MI | 2023-09-21 | 2023-02-19+ | NUVB | NODELMAN OLEG | Dir | P - Purchase | $1.26 | +5.31M | 12.50M | +74% | +$6.71M |
| D | 2023-03-02 | 2021-03-02 | NUVB | Hung David | Pres, CEO, Dir, 10% | J - Other | $0.00 | -368.4K | 58.28M | -0.6% | $0 |
| MI | 2022-12-05 | 2022-11-30+ | NUVB | FALBERG KATHRYN E | Dir | P - Purchase | $1.93 | +250.0K | 207.0K | New | +$483.1K |
| 2022-04-07 | 2022-04-05 | NUVB | Omega Fund V GP Manager, Ltd. | 10% | S - Sale | $5.60 | -2.50M | 20.46M | -11% | -$14.00M | |
| 2021-12-17 | 2021-12-15 | NUVB | Omega Fund IV GP, L.P. | 10% | S - Sale | $10.07 | -500.0K | 22.96M | -2% | -$5.04M | |
| 2021-12-09 | 2021-12-07 | NUVB | Omega Fund V, L.P. | 10% | S - Sale | $9.80 | -1.40M | 23.46M | -6% | -$13.72M | |
| MI | 2021-11-30 | 2021-03-31+ | NUVB | EcoR1 Capital, LLC | Affiliate of Dir | P - Purchase | $8.89 | +393.2K | 6.74M | +6% | +$3.50M |
| MI | 2021-11-30 | 2021-03-31+ | NUVB | EcoR1 Capital, LLC | Affiliate of Dir | S - Sale | $9.96 | +94.9K | 1.15M | +9% | +$945.5K |
| M | 2021-11-24 | 2021-11-22+ | NUVB | Omega Fund V GP Manager, Ltd. | 10% | S - Sale | $9.76 | -295.0K | 24.86M | -1% | -$2.88M |
| 2021-11-05 | 2021-11-03 | NUVB | Omega Fund V GP, L.P. | 10% | S - Sale | $9.25 | -2.00M | 25.15M | -7% | -$18.50M | |
| M | 2021-11-01 | 2021-10-28+ | NUVB | Omega Fund V GP Manager, Ltd. | 10% | S - Sale | $9.59 | -1.06M | 27.20M | -4% | -$10.16M |
Purchase Sale Sale after option exercise All abbreviations